PROGRAMME
Kindly note that the programme is tentative and may be subject to changes.
CONGRESS DAY 1
Date: 14 August 2025 (Thursday)
Venue: The Ngee Ann Kongsi (NAK) Auditorium, Academia, SGH Campus, 20 College Road, Singapore 169856
Time (in SGT)
Programme
Speaker
0800 - 0850
Welcome Reception and Registration
0900 - 0930
Conference Opening
Delivering on the Promise of Cell Therapy in Asia – Quality, Access, Affordability
Dr Cheong Wei Yang
Guest-of-Honour, ACTRIS Committee Chairman
0930 - 1020
Plenary Session
The Current Landscape of Cell and Gene Therapy
Chairpersons: Prof Akihiro Shimosaka and Prof Mickey B C Koh
0930 - 0955
The GoCART Coalition
Prof Christian Chabannon
Institut Paoli-Calmettes Comprehensive Cancer Center, France
0955 - 1020
The New EU Regulation on Substances of Human Origin (SoHO)
Dr Stefaan Van Der Spiegel
Sector - Substance of Human Origin (SoHO - blood, tissue, cells, organs), European Commission, Belgium
1020 - 1050
Morning Tea Break
IMMUNE CELL THERAPY SESSION 1 - CAR-T Therapy / TILs
Chairperson: Clin Asst Prof Chen Yunxin
1050 - 1110
CD7 CAR-T for Treating Hematological Malignancies
Dr Peggy Lu
Lu Daopei Hospital, China
1110 - 1130
Advancing CAR T-cell Success in Lymphomas
Dr Ong Shin Yeu
Singapore General Hospital, Singapore
1130 - 1150
TILs in Solid Tumours
Asst Prof Sophia Wong
National Cancer Centre Singapore, Singapore
1150 - 1210
IPS Derived T-cell Therapy
Prof Shin Kaneko
Kyoto University, Japan
1210 - 1220
Question and Answer
All Speakers
1220 - 1350
Lunch Break
1250 - 1350
Sponsored Seminar Session by Miltenyi Biomedicine
Zamtocabtagene Autoleucel (Zamto-cel): Global and APAC Developments and Insights
by Dr Linda Hanssens
Innovative Approaches in CAR-T Cell Programs in China and Singapore
by Prof Leung Wing Hang
Clinical Insights and Experiences with CAR-T Therapies
by Prof Mickey B C Koh
Chairperson: Dr Linda Hanssens
GENE THERAPY SESSION
Chairperson: A/Prof Citra Mattar
1350 - 1410
In vivo Genome Editing Treatment for Monogenetic Diseases
Prof Tsukasa Ohmori
Jichi Medical University School of Medicine, Japan
1410 - 1430
Thalassemia
Prof Suradej Hongeng
Bumrungrad International Hospital, Thailand
1430 - 1450
Next Generation iPSC-derived Platelet Product
Prof Koji Eto
Kyoto University, Japan
1450 - 1500
Question and Answers
All Speakers
1500 - 1530
Afternoon Tea Break
IMMUNE CELL THERAPY SESSION 2 - MSCs and Exosomes (Immunomodulation)
Chairperson: Prof Mickey B C Koh
1530 - 1550
Treating Neurodegenerative Disorders with Allogeneic Platelet-based Therapy
Distinguished Prof Thierry Burnouf
Taipei Medical University, Taiwan
1550 - 1610
MSC Exosomes in Disease Modulation: Immunity as the Common Denominator
Uncovering how immune pathway modulation drives the broad therapeutic potential of MSC-derived extracellular vesicles
Dr Lim Sai Kiang
Paracrine Therapeutics, Singapore
1610 - 1630
MSC 2.0: Non-Viral Gene-Modified Stem Cells in the Translational Pipeline for Oncology
A/Prof Too Heng-Phon
Bioprocess Technology Institute, A*STAR, Singapore
1630 - 1650
Mesenchymal Stem / Stromal Cell (MSC) Therapy for Cardiovascular Disease
Dr Wannhsin Chen
Hexun Biosciences, Taiwan
1650 - 1700
Question and Answers
All Speakers
1700 - 1730
Sponsored Seminar Session by Shibuya Corporation
Cell Culturing System for Industrialization
by Mr Masataka Watanabe
1800 - 2100
Speakers' Dinner (For invited guests only)